通过使用卷轴-卷轴脂改性膜融合药物递送系统来对抗抗抗肺癌
Xi Wang1, Guiquan Liu1, Xueyu Pu1
1State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, China.
概括
这项研究引入了一种新的膜融合药物递送系统 (MF-DDS),用于对抗抗西斯的肺癌. MF-DDS有效地将化疗药物直接输送到耐药癌细胞中,克服药物外流机制并提高治疗效率.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症研究 癌症研究
背景情况:
- 癌症化疗中的耐药性是一个重大的临床挑战,导致治疗失败.
- 耐药癌细胞通过控制吸收和增强排泄来减少细胞内药物积累,从而限制化疗的疗效.
- 肺癌 (A549-DDP) 中的西斯普拉丁 (DDP) 耐药性需要创新的治疗策略.
研究的目的:
- 开发和评估一种新的膜融合药物递送系统 (MF-DDS),用于治疗抗西斯的肺癌.
- 研究MF-DDS在通过直接细胞质输送DDP来克服耐药性的机制.
- 评估MF-DDS的体外和体内疗效,与免费的DDP相比.
主要方法:
- 使用补充的卷轴-卷轴形成 (CP8K4/CP8E4) 构建MF-DDS进行膜融合.
- 用CP8K4装饰A549-DDP细胞,并与CP8E4装载DP (PLGA-DDP@LB-CP8E4) 的修饰PLGA纳米粒子相互作用.
- 在体外细胞毒性 (IC50) 和体内瘤生长抑制的评估,以及对药物排泄蛋白基因表达的分析 (MRP1,MRP2,ABCG2).
主要成果:
- 与自由DDP相比,MF-DDS在体外实现了A549-DDP细胞的IC50减少13.42倍.
- 在体内研究显示,瘤大小显著减少,治疗瘤的重量仅为原始重量的1/5.26.
- MF-DDS有效地抑制了关键药物流量蛋白基因 (MRP1,MRP2,ABCG2) 的表达,增强了细胞内药物积累.
结论:
- 开发的MF-DDS系统显示出克服肺癌中西斯普拉丁耐药性的巨大潜力.
- 通过膜融合直接输送DDP的细胞质,有效地向并消除耐药癌细胞.
- 这种方法代表了药物耐药瘤的药理疗法的有希望的进步.
相关概念视频
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K


